
Addressing the Threat of Drug-Resistant Tuberculosis
Robert Giffin, Sally Robinson
₹2,751

Drug Development for Rare and Neglected Diseases and Individualized
by Robert Giffin, Theresa M. Wizemann, Institute of Medicine (U. S.), Sally Robinson
Natl Academy Pr · 2009
Free delivery. Nothing extra to pay at checkout.
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized is written by Robert Giffin, Theresa M. Wizemann & others. This edition from Natl Academy Pr (2009) has 131 pages.
Its main subjects are Government policy, Drugs, Economics and Economic Models. Places discussed include United States.